What does BRAINS mean in BRITISH MEDICINE
The Bayer Randomised Acute Ischemia Neuroprotectant Study (BRAINS) is a clinical trial that aims to assess the safety and efficacy of neuroprotectants for acute ischemic stroke. BRAINS was conducted by Bayer, a leading pharmaceutical company, in collaboration with several other partners. The primary objective of BRAINS was to determine if neuroprotective agents can reduce neurological damage following an acute ischemic stroke.
BRAINS meaning in British Medicine in Medical
BRAINS mostly used in an acronym British Medicine in Category Medical that means Bayer Randomised Acute Ischemia Neuroprotectant Study
Shorthand: BRAINS,
Full Form: Bayer Randomised Acute Ischemia Neuroprotectant Study
For more information of "Bayer Randomised Acute Ischemia Neuroprotectant Study", see the section below.
Essential Questions and Answers on Bayer Randomised Acute Ischemia Neuroprotectant Study in "MEDICAL»BRITMEDICAL"
What type of study is BRAINS?
BRAINS is a clinical trial that aims to assess the safety and efficacy of neuroprotectants for acute ischemic stroke.
Who conducted BRAINS?
BRAINS was conducted by Bayer, a leading pharmaceutical company, in collaboration with several other partners.
What is the primary objective of BRAINS?
The primary objective of BRAINS was to determine if neuroprotective agents can reduce neurological damage following an acute ischemic stroke.
Are there any other goals of the study?
Yes, secondary objectives include evaluating changes in patients' clinical outcomes, imaging results and biomarkers up to 90 days after the onset of symptoms.
How long does the study last?
Patients are followed for up to six months after enrollment in the study.
BRAINS also stands for: |
|
| All stands for BRAINS |